Clinical Trials Directory

Trials / Completed

CompletedNCT03787030

Application of Vitamin E on Anal Fissure

Application of Vitamin E Acetate Ointment vs Nitroglycerin Ointment for the Treatment of Chronic Anal Fissure

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Hospital General Universitario Elche · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Patients were randomized into 2 groups: * Vitamin E: Vitamin E ointment will be applied during 8 weeks * Nitroglycerin: Nitroglycerin ointment will be applied during 8 weeks Healing rate of chronic anal fissure in patients receiving Nitroglycerin ointment and subjects patients receiving Vitamin E ointment were evaluated .

Detailed description

Patients were randomly assigned to experimental and control groups: those patients receiving vitamin E ointment (Experimental Group - EG) and those receiving glyceryl trinitrate ointment (Control Group - CG). Treatments: Glyceryl trinitrate ointment (GTO): Commercially available aluminium tubes containing 0.4 glyceryl trinitrate ointment (Rectogesic, proStrakan Group, Galashiels, UK) were purchased from pharmacies. The dosage for all the patients was 375 mg of ointment (containing 1.5 mg of glyceryl trinitrate), applied with a gloved finger to the distal anal canal, every 12 hours for an 8-week period. Vitamin E acetate ointment (VEA): Commercially available plastic tubes containing VitaminE acetate ointment (Filme Olio, Hulka SRL, Italy) were purchased from pharmacies. The dosage for all the patients was 1ml, applied with a gloved finger to the distal anal canal, every 12 hours for an 8-week period. Healing rate of chronic anal fissure was investigated.

Conditions

Interventions

TypeNameDescription
DRUGVitamin E Acetate ointmentApplication of 1 ml of ointment to the distal anal canal, every 12 hours for an 8-week period.
DRUGGlyceryl trinitrate ointmentApplication of 375 mg of ointment to the distal anal canal, every 12 hours for an 8-week period.

Timeline

Start date
2018-12-21
Primary completion
2019-02-28
Completion
2019-02-28
First posted
2018-12-26
Last updated
2020-04-22

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03787030. Inclusion in this directory is not an endorsement.